Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer

Figure 2 Effects of glycosylation inhibitors on Panc-1 and Capan-1 cell proliferation. MTT assays were performed to assess inhibitory curves of Panc-1 and Capan-1 cells treated with different concentrations of A: Tunicamycin or B: Benzyl-N-acetyl-α-galactosaminide (BAG) for 48 h; and for various times with 2.0% tunicamycin or 5.0 mmol/L BAG in C: Panc-1 cells; or D: Capan-1 cells. MTT: 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide.